Annual Meeting Archives
2016
Enhanced antitumor efficiency by thermosensitive liposome with high-intensity focused ultrasound
Category:
Overcoming Biological Barriers in Drug Delivery
Institutions:
(1) Sungkyunkwan University, Korea
Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibodies
Category:
Peptides, Proteins, and Vaccines
Institutions:
(1) University of North Carolina at Chapel Hill, U.S.A.; (2) NCSU, U.S.A.
Enhancement of EPR effect in nanomedicine with nitric oxide-releasing liposome
Category:
Physical Oncology: Modulating Tumor Microenvironment for Drug Delivery
Institutions:
(1) Department of Applied Chemistry, Faculty of Engineering, Kyushu University, Japan
Enhancement of Tableting Properties of a Poorly Compressible, High-dose Drug by Melt Granulation: An Application of QbD Approach
Category:
Oral Delivery
Institutions:
(1) Institute of Chemical Technology, India
Enhancing Blood Perfusion in Tumor Tissue by preventing Tumor associated Thrombosis using oral Heparin to improve the Distribution of Anti-cancer drugs
Category:
Physical Oncology: Modulating Tumor Microenvironment for Drug Delivery
Institutions:
(1) College of Pharmacy, Seoul National University, Korea
Enteric Coating of Micronized API Particles using a Wurster Fluid-Bed Process
Category:
Delivery Technologies in Nutraceuticals, Food, and Oral Products
Institutions:
(1) Biogen, U.S.A.
Enzymatic and Anti-Tumorigenic Effect of PH20-Expressing Exosome
Category:
Thinking Outside the Box Delivery Technologies: Nanocarriers from Nature
Institutions:
(1) Korea Institute of Science and Technology, Korea
Evaluation of Acid-labile PAMAM-Doxorubicin Conjugates on an in vitro Lung Adenocarcinoma Model and their Pseudo-Solution Formulation in Pressurized Metered-Dose Inhalers
Category:
Local Drug Delivery
Institutions:
(1) Virginia Commonwealth University, U.S.A.
Evaluation of Efficacy and Toxicity of a Bone-targeted pH-sensitive Liposomal Formulation Containing Doxorubicin in an Animal Model of Breast-metastatic Tumor in Bones
Category:
Preclinical Science Challenges to Drug Delivery
Institutions:
(1) Massachusetts General Hospital/Harvard Medical School, U.S.A.; (2) Universidade Federal de Minas Gerais, Brazil
Evaluation of EUDRAGIT® NM 30 D as a Binder in Drug Layering on Pellets
Category:
Oral Delivery
Institutions:
(1) EVONIK INDIA PRIVATE LIMITED, India
Evaluation of Fractional Laser Ablation for the Controlled Transdermal Delivery of Paliperidone and the Development of a Mathematical Model for Laser-Assisted Drug Transport
Category:
Transdermal Delivery
Institutions:
(1) University of Geneva, Switzerland; (2) Universidad CEU Cardenal Herrera, Spain; (3) Universidad de Valencia, Spain
Evaluation of in vitro evaporation profile of a natural insect repellent (citronella oil) impregnate in mesoporous silica
Category:
Delivery Technologies in Cosmetics, Personal Care, and Household Products
Institutions:
(1) UNIVERSIDAD DE COLIMA, Mexico; (2) UNIVERSIDAD AUTONOMA DE NAYARIT, Mexico
Evaluation of in vitro tests to reduce animal testing in drug toxicology studies
Category:
Predictive Modeling in Delivery and Targeting (Scaling: Mouse to Man
Institutions:
Stochastic Process in System Distribution)
Evaluation of Newly-Developed Hypromellose Acetate Succinate (HPMCAS) for Spray Dried Solid Dispersions of Poorly-Soluble Drugs
Category:
New Processes, New Materials, New Products
Institutions:
(1) Ashland Specialty Ingredients, U.S.A.
Ex-Vivo Intraocular Model to Investigate Long-Term Protein stability in the Vitreous Humor
Category:
Parenteral Systemic Delivery of Biopharmaceuticals: Overcoming Product Development and Regulatory Challenges
Institutions:
(1) Pharmaceutical Development and Supplies PTD (Biologics Europe), F. Hoffmann-La Roche Ltd, Basel, Switzerland, Switzerland; (2) Pharmaceutical Development and Supplies PTD (Biologics Europe), F. Hoffmann-La Roche Ltd, Basel, Switzerland, Switzerland
Exosome mimetics-based platform technology for targeted drug delivery and adjuvant-free vaccine
Category:
Thinking Outside the Box Delivery Technologies: Nanocarriers from Nature
Institutions:
(1) POSTECH, Korea
Exploring Cry protein crystals as a platform to display of tubercle antigens
Category:
Peptides, Proteins, and Vaccines
Institutions:
(1) The Chinese University of Hong Kong, Hong Kong; (2) Aaron Diamond AIDS Research Center, Rockefeller University, U.S.A.; (3) The Ohio State University, U.S.A.
Exploring MicroRNA Expression Profiles Related to Cell Death Pathways in Mouse Embryonic Fibroblast Cells Treated with Polyethylenimine
Category:
Oligonucleotide Delivery: New Applications and Opportunities
Institutions:
(1) Department of Pharmacy, Chia Nan University of Pharmacy and Science, Taiwan; (2) Institute of Microbiology and Immunology, Chung Shan Medical University, Taiwan
Extended Release Cysteamine Nanowafer as an Efficacious Treatment Modality for Corneal Cystinosis
Category:
Ocular Drug Delivery
Institutions:
(1) Baylor College of Medicine, U.S.A.; (2) University of California, U.S.A.
Fabrication of starch-based nanofibrous mats for wound healing applications
Category:
Tissue Engineering
Institutions:
(1) Institute of Chemical Technology, India
Fact of PEG-related antibody generation and its relation to accelerated blood clearance
Category:
Integration of Imaging and Drug Delivery
Institutions:
(1) The Jikei University School of Medicine, Japan; (2) Hoshi University, Japan
Fast track development applied to softgel formulation using quality by design (QbD)
Category:
Oral Delivery
Institutions:
(1) Catalent Pharma Solutions, France
FcBP-modified Nanoparticles Transport across the Intestinal Epithelium
Category:
Oral Delivery
Institutions:
(1) Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China
Feasibility of subcutaneous entecavir implants for chronic hepatitis B treatment
Category:
Parenteral Systemic Delivery of Biopharmaceuticals: Overcoming Product Development and Regulatory Challenges
Institutions:
(1) Merck and Co., U.S.A.
Flame Retardant Encapsulation for Preparation of Nanofoams
Category:
Encapsulation and Controlled Release for Industrial Applications
Institutions:
(1) The Dow Chemical Company, U.S.A.